Possible aggravation of abdominal symptoms by tolbutamide in a patient with diabetes and hepatic porphyria.
作者信息
SCHLESINGER F G
出版信息
Acta Med Scand. 1961 Apr;169:433-5. doi: 10.1111/j.0954-6820.1961.tb07853.x.
Abstract
摘要
相似文献
1
Possible aggravation of abdominal symptoms by tolbutamide in a patient with diabetes and hepatic porphyria.甲苯磺丁脲可能会加重一名糖尿病合并肝性卟啉病患者的腹部症状。
Acta Med Scand. 1961 Apr;169:433-5. doi: 10.1111/j.0954-6820.1961.tb07853.x.
2
Porphyria cutanea tarda and diabetes.迟发性皮肤卟啉症与糖尿病
Br Med J. 1960 Mar 19;1(5176):860-1. doi: 10.1136/bmj.1.5176.860.
3
Porphyria, diabetes, and their relationship. A case report.
Arch Dermatol. 1961 May;83:717-22. doi: 10.1001/archderm.1961.01580110005001.
4
Hepatic porphyria with pancreatic involvement: report of a case.伴有胰腺受累的肝性卟啉病：一例报告
Am J Dig Dis. 1963 May;8:454-9. doi: 10.1007/BF02232001.
5
[Porphyria and diabetes mellitus; detection of porphyria in diabetics].[卟啉病与糖尿病；糖尿病患者中卟啉病的检测]
Z Gesamte Inn Med. 1956 Feb 15;11(4):186-8.
6
[Porphyria cutanea tarda (PCT) and diabetes mellitus].迟发性皮肤卟啉病（PCT）与糖尿病
Z Hautkr. 1977 Dec 1;52(23):1165-74.
7
[Allergic thrombocytopenia in tolbutamide therapy of diabetes mellitus].[糖尿病甲苯磺丁脲治疗中的过敏性血小板减少症]
Med Welt. 1962 Sep 8;36:1899-903.
8
9
[Porphyria cutanea tarda, vasculitis allergica, diabetes mellitus].迟发性皮肤卟啉病、变应性血管炎、糖尿病
Z Hautkr. 1975 Oct 1;50(19):838.
10
[On the occurrence of porphyria in diabetes mellitus].[关于糖尿病中卟啉症的发生]
Z Gesamte Inn Med. 1959 Aug 15;14:785-7.
引用本文的文献
1
[THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].[低血糖磺酰胺类药物治疗中的血液学风险]
Bull World Health Organ. 1964;31(1):95-100.
Zotero 插件